Comparison

KU-60019 European Partner

Item no. S1570-10
Manufacturer Selleckchem
CASRN 925701-49-1
Amount 10 mg
Category
Type Inhibitors
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 925701-49-1'
Similar products KU-60019
Available
Cell lines
U87 and U1242
Chemical Name
2-((2S, 6R)-2, 6-dimethylmorpholino)-N-(5-(6-morpholino-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide
Concentrations
Dissolved in water, final concentrations ca.3 uM
Description
KU-60019 is a potent and specific ATM inhibitor with IC50 of 6.3 nM.
Features
An improved analog of KU-55933, more effective at blocking ATM-mediated DDR events.
IC50
6.3 nM [1], 6.3 nM [1], 6.3 nM [1], 6.3 nM [1], 6.3 nM [1], 6.3 nM [1]
In vitro
Compared to KU-55933, KU-60019 is an improved more water-soluble inhibitor of the ATM kinase, while displaying similar target selectivity. KU-60019 has little activity against DNA-PKcs and ATR with IC50 values of 1.7 uM and >10 uM, respectively, as well as 229 other protein kinases such as PI3K, mTOR and mTOR/FKBP12. KU-60019 displays 3- to 10-fold more potency than KU-55933 at blocking radiation-induced phosphorylation of key ATM protein targets such as p53, gamma-H2AX, and CHK2, in human glioma U87 and U1242 cells, as 1 uM of KU-60019 significantly induces >70% decrease of p53 (S15) phosphorylation to which extent ca.10 uM of KU-55933 is required to achieve. KU-60019 effectively radiosensitizes human glioma cells with dose-enhancement ratio of 1.7 and 4.4 at 1 uM and 10 uM, respectively, and also radiosensitizes the normal fibroblasts but not the A-T fibroblasts. KU-60019 treatment (3 uM) blocks basal and insulin-induced AKT S473 phosphorylation by 70% and ca.50%, respectively, and completely reduces radiation-induced AKT phosphorylation below the level of control. The effect of KU-60019 on AKT S473 phosphorylation can be seen in glioma cell lines and normal fibroblasts but not in A-T (h-TERT) cells, and can be significantly blocked by phosphatase inhibitor okadaic acid, suggesting a critical role of ATM kinase in regulating AKT phosphorylation via unknown phosphatase. Consistent with the inhibition of prosurvival AKT signaling, KU-60019 at 3 uM significantly inhibits migration and invasion of human glioma U87 cells by >70% and ca.60%, respectively, as well as U1242 cells by >50% and ca.60% respectively. [1]
Incubation Time
1, 3, and 5 days
Method
Cells are exposed to KU-60019 for 1, 3, and 5 days. Cell growth is determined by AlamarBlue. AlamarBlue is added to the medium to the recommended final concentration. Plates are incubated for 1 hour at 37 C, fluorescence is determined on a Fluoro-Count plate reader (excitation 530 nm, emission 590 nm), and values are taken as a measure of cell growth. Cell survival is determined by trypan blue/fluorescence activated cell sorting (FACS) assay.
Molecular Weight (MW)
547, 67
Picture ChemicalStructure Description
KU-60019 Chemical Structure
Solubility (25C)
DMSO 40 mg/mL, Water <1 mg/mL, Ethanol 30 mg/mL
Storage
2 years -20CPowder, 2 weeks4Cin DMSO, 2 months-80Cin DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close